Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Continuous Hypertonic Saline in Traumatic Brain Injury
2024-520205-39-00Phase 3Authorised
- Sponsor
- CHU de Nantes
- Start
- Aug 2025
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of sodium chloride and Bronchitol in traumatic brain injury (TBI) (2 arms), sponsored by CHU de Nantes. Planned start Aug 2025; status: authorised.
02
Drugs
sodium chlorideBronchitol
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on 2024-520205-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520205-39-00.